MolGen to attend the AACC Conference in Atlanta, GA MolGen b.v. of Utrecht (NL) is preparing to attend the Annual Meeting & Clinical Lab Expo of the American Association For Clinical Chemistry, September 26-30. With over 35,000 attendees and 3,100 exhibitors from...
Agreement will connect SpeeDx chemistry with the extensive range of MolGen equipment for a fully integrated, high-throughput sample-to-answer workflow SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of...
MolGen Expands DNA/RNA Extraction Product Offering to US Market with MolGen USA US Operation Launch Establishes a Reliable Single-Source Supply Chain for SARS-CoV-2 Testing MolGen B.V., a single-source supplier of DNA/RNA extraction technology and services for the...
We are proud to announce our new logo and corporate style! The growth of MolGen in the last year is what made our company what it is today. We felt it was important to adjust our corporate style to the progress we made in such a short amount of time. Our new logo...
Veenendaal, March 02, 2021 – Today, MolGen, specializing in molecular biology and DNA/RNA extraction and laboratory automation, has announced its acquisition of LabTIE International. With this acquisition, MolGen strengthens its position in offering complete solutions...
MolGen b.v. of Utrecht (NL) will be handling the entire setup of the mobile labs and supplying the consumables for public health authority test centres in cities including Amsterdam, Rotterdam, and Utrecht. Agreements have been signed with the Ministry of Health and...
Recent Comments